| pubmed-article:8647520 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:8647520 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:8647520 | lifeskim:mentions | umls-concept:C0085669 | lld:lifeskim |
| pubmed-article:8647520 | lifeskim:mentions | umls-concept:C0014550 | lld:lifeskim |
| pubmed-article:8647520 | lifeskim:mentions | umls-concept:C0009011 | lld:lifeskim |
| pubmed-article:8647520 | lifeskim:mentions | umls-concept:C0199176 | lld:lifeskim |
| pubmed-article:8647520 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:8647520 | pubmed:dateCreated | 1996-7-23 | lld:pubmed |
| pubmed-article:8647520 | pubmed:abstractText | A prospective neurological and electroencephalographic (EEG) study was performed in sixteen leukemia patients receiving busulfan (BU) and cyclophosphamide before autologous bone marrow transplantation. All patients were given anticonvulsant prophylaxis with a combination of phenobarbital (PB) and clonazepam (CLZ). Neurological examination and EEG were performed prior to and soon after completion of BU treatment and were repeated two months later. No tonic-clonic and/or myoclonic convulsions were observed. In two patients, comparison of EEG recorded before and upon completion of BU administration revealed modification of features. EEG re-evaluated two months after BU showed normalization in one of the two patients. BU may trigger both generalized and myoclonic seizures together with EEG abnormalities; PB combined with CLZ may be useful prophylactic treatment. | lld:pubmed |
| pubmed-article:8647520 | pubmed:language | eng | lld:pubmed |
| pubmed-article:8647520 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8647520 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:8647520 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8647520 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8647520 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8647520 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:8647520 | pubmed:issn | 0390-6078 | lld:pubmed |
| pubmed-article:8647520 | pubmed:author | pubmed-author:IannettiPP | lld:pubmed |
| pubmed-article:8647520 | pubmed:author | pubmed-author:MeloniGG | lld:pubmed |
| pubmed-article:8647520 | pubmed:author | pubmed-author:PintoR MRM | lld:pubmed |
| pubmed-article:8647520 | pubmed:author | pubmed-author:RaucciUU | lld:pubmed |
| pubmed-article:8647520 | pubmed:author | pubmed-author:SpaliceAA | lld:pubmed |
| pubmed-article:8647520 | pubmed:author | pubmed-author:NastaLL | lld:pubmed |
| pubmed-article:8647520 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:8647520 | pubmed:volume | 80 | lld:pubmed |
| pubmed-article:8647520 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:8647520 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:8647520 | pubmed:pagination | 532-4 | lld:pubmed |
| pubmed-article:8647520 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
| pubmed-article:8647520 | pubmed:meshHeading | pubmed-meshheading:8647520-... | lld:pubmed |
| pubmed-article:8647520 | pubmed:meshHeading | pubmed-meshheading:8647520-... | lld:pubmed |
| pubmed-article:8647520 | pubmed:meshHeading | pubmed-meshheading:8647520-... | lld:pubmed |
| pubmed-article:8647520 | pubmed:meshHeading | pubmed-meshheading:8647520-... | lld:pubmed |
| pubmed-article:8647520 | pubmed:meshHeading | pubmed-meshheading:8647520-... | lld:pubmed |
| pubmed-article:8647520 | pubmed:meshHeading | pubmed-meshheading:8647520-... | lld:pubmed |
| pubmed-article:8647520 | pubmed:meshHeading | pubmed-meshheading:8647520-... | lld:pubmed |
| pubmed-article:8647520 | pubmed:meshHeading | pubmed-meshheading:8647520-... | lld:pubmed |
| pubmed-article:8647520 | pubmed:meshHeading | pubmed-meshheading:8647520-... | lld:pubmed |
| pubmed-article:8647520 | pubmed:meshHeading | pubmed-meshheading:8647520-... | lld:pubmed |
| pubmed-article:8647520 | pubmed:meshHeading | pubmed-meshheading:8647520-... | lld:pubmed |
| pubmed-article:8647520 | pubmed:meshHeading | pubmed-meshheading:8647520-... | lld:pubmed |
| pubmed-article:8647520 | pubmed:meshHeading | pubmed-meshheading:8647520-... | lld:pubmed |
| pubmed-article:8647520 | pubmed:articleTitle | Clonazepam prophylaxis and busulfan-related myoclonic epilepsy in autografted acute leukemia patients. | lld:pubmed |
| pubmed-article:8647520 | pubmed:affiliation | Department of Biopathology, University La Sapienza, Rome, Italy. | lld:pubmed |
| pubmed-article:8647520 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:8647520 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8647520 | lld:pubmed |
